Passage Bio, Inc. (PASG)
NASDAQ·Healthcare·Biotechnology
$3.40
—
Mkt Cap $27.94M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$10.00
Range $7.00 – $15.00
Implied Upside
+194.1%
Consensus $10.00 vs current $3.40
NASDAQ·Healthcare·Biotechnology
$3.40
—
Mkt Cap $27.94M
No recent rating data.
Price Target (4 analysts)
$10.00
Range $7.00 – $15.00
+194.1%
Consensus $10.00 vs current $3.40